Ledger.Open graph →
SEC Form D · filed March 15, 2022

Sherlock Biosciences, Inc

Offering
$80.0M
Sold
$80.0M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
BRIGHTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Michael Rubin · Boston, MEDirectorDavid Walt · Cambridge, MADirectorMichael Rubin · ARLINGTON, VADirectorIssi Rozen · Cambridge, MADirectorJames Collins · Plano, TXDirectorBryan Dechairo · Brighton, MAExec · DirectorMichael Rubin · Conshohocken, PADirectorIssi Rozen · Cambridge, MADirectorDavid Walt · Cambridge, MADirectorJames Collins · Cambridge, MADirectorBryan Dechairo · Brighton, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗